Oncora Funding: How Much Did They Raise & Key Investors

How Much Did Oncora Raise?
Funding & Key Investors

Oncora has successfully secured a total capital infusion of $2.5M, marking a significant milestone in its trajectory within the healthcare technology sector. The most recent strategic investment of $1.3M underscores the market confidence in the company's specialized approach to oncology data management. By consolidating its financial position, Oncora is well-positioned to accelerate the deployment of its intelligent registry solutions across complex clinical environments.

This latest financing round reflects a broader trend of institutional interest in digital health infrastructure, specifically targeting the optimization of cancer registry workflows. As the company transitions from its foundational development phase into a more robust scaling operation, the influx of capital provides the necessary runway to enhance its proprietary software suite and expand its footprint within major healthcare facilities.

What is Oncora?

Oncora

Software

Healthcare Software

Oncora operates at the intersection of oncology and medical informatics, providing a sophisticated Cancer Registry Assistant designed to automate and refine quality control processes. In an era where clinical data accuracy is paramount for patient outcomes and regulatory compliance, Oncora offers a critical solution for cancer registries struggling with manual data entry and fragmented information systems. By leveraging advanced algorithmic processing, the platform enables healthcare providers to maintain high standards of data integrity, ultimately facilitating better research and operational efficiency. The company serves a vital role in the healthcare ecosystem, transforming how institutions manage the lifecycle of cancer-related data.

How much funding has Oncora raised?

Oncora has raised a total of $2.5M across 2 funding rounds:

2016

Angel/Seed

$1.2M

2017

Unspecified

$1.3M

Angel/Seed (2016): $1.2M with participation from iSeed Ventures and BioAdvance

Unspecified (2017): $1.3M, investors not publicly disclosed

Key Investors in Oncora

iSeed Ventures

iSeed Ventures is a San Francisco-based venture capital firm that invests in innovative companies across various sectors, particularly those leveraging AI technology.

BioAdvance

BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life.

Undisclosed Investors

What's next for Oncora?

With the recent capital injection, Oncora is poised to scale its enterprise-level operations, focusing on product iteration and market penetration. The strategic roadmap likely involves deepening the integration of its Cancer Registry Assistant with existing electronic health record systems to ensure seamless data interoperability. Furthermore, the company is expected to prioritize the expansion of its sales and support infrastructure to meet the growing demand for automated registry solutions. As Oncora continues to refine its technology, the focus will remain on driving clinical efficiency and supporting the long-term data management needs of large-scale cancer centers and research institutions.

See full Oncora company page

See More Financial Insights